PISAPIA, PASQUALE
 Distribuzione geografica
Continente #
AS - Asia 4.759
EU - Europa 3.337
NA - Nord America 2.832
SA - Sud America 614
AF - Africa 92
OC - Oceania 8
Continente sconosciuto - Info sul continente non disponibili 2
Totale 11.644
Nazione #
US - Stati Uniti d'America 2.703
SG - Singapore 2.634
RU - Federazione Russa 1.762
CN - Cina 985
IT - Italia 763
HK - Hong Kong 527
BR - Brasile 512
VN - Vietnam 239
DE - Germania 237
IN - India 134
GB - Regno Unito 94
NL - Olanda 91
FI - Finlandia 82
KR - Corea 73
CA - Canada 62
FR - Francia 61
ES - Italia 55
MX - Messico 46
AR - Argentina 41
UA - Ucraina 39
ZA - Sudafrica 30
BD - Bangladesh 26
IE - Irlanda 26
EC - Ecuador 23
AT - Austria 21
PL - Polonia 21
CI - Costa d'Avorio 19
SE - Svezia 18
IQ - Iraq 16
JP - Giappone 16
TR - Turchia 16
LT - Lituania 14
ID - Indonesia 13
PK - Pakistan 13
UZ - Uzbekistan 10
PE - Perù 9
VE - Venezuela 9
BE - Belgio 7
EG - Egitto 7
JO - Giordania 7
PY - Paraguay 7
KE - Kenya 6
RS - Serbia 6
SA - Arabia Saudita 6
AU - Australia 5
CH - Svizzera 5
HU - Ungheria 5
MA - Marocco 5
RO - Romania 5
AE - Emirati Arabi Uniti 4
AL - Albania 4
AZ - Azerbaigian 4
CL - Cile 4
DZ - Algeria 4
NP - Nepal 4
TN - Tunisia 4
BG - Bulgaria 3
BS - Bahamas 3
CO - Colombia 3
CZ - Repubblica Ceca 3
GA - Gabon 3
GR - Grecia 3
HN - Honduras 3
IL - Israele 3
KH - Cambogia 3
KZ - Kazakistan 3
MY - Malesia 3
OM - Oman 3
PA - Panama 3
PH - Filippine 3
TZ - Tanzania 3
AD - Andorra 2
BO - Bolivia 2
CR - Costa Rica 2
GF - Guiana Francese 2
GT - Guatemala 2
IR - Iran 2
JM - Giamaica 2
KG - Kirghizistan 2
MD - Moldavia 2
NG - Nigeria 2
NI - Nicaragua 2
NZ - Nuova Zelanda 2
PT - Portogallo 2
TW - Taiwan 2
UY - Uruguay 2
AM - Armenia 1
BN - Brunei Darussalam 1
BY - Bielorussia 1
CD - Congo 1
CV - Capo Verde 1
DM - Dominica 1
EE - Estonia 1
ET - Etiopia 1
EU - Europa 1
GD - Grenada 1
GE - Georgia 1
GH - Ghana 1
HT - Haiti 1
LA - Repubblica Popolare Democratica del Laos 1
Totale 11.628
Città #
Singapore 1.307
Hong Kong 520
Moscow 440
Hefei 388
Chandler 365
Beijing 255
Ashburn 253
Naples 175
Santa Clara 135
Millbury 103
Ho Chi Minh City 100
Munich 99
Los Angeles 98
Lawrence 86
Des Moines 76
Seoul 72
Milan 68
Redondo Beach 67
Kochi 63
Napoli 54
São Paulo 53
Buffalo 52
Helsinki 45
Boston 43
Hanoi 43
Rome 42
Wilmington 42
Amsterdam 41
New York 37
Valencia 37
Dallas 36
The Dalles 33
Frankfurt am Main 29
Seattle 24
Nanjing 22
Mexico City 21
Ottawa 20
Rio de Janeiro 20
Falkenstein 19
Johannesburg 19
Chennai 18
Fairfield 18
London 18
Turku 17
Chicago 16
Atlanta 15
Brooklyn 15
Dublin 15
Nuremberg 15
Orem 15
Warsaw 15
Houston 14
Montreal 14
Tokyo 14
Da Nang 13
Brasília 12
Haiphong 12
Lappeenranta 12
Princeton 12
Stockholm 12
Belo Horizonte 11
Denver 11
Düsseldorf 11
Phoenix 11
Redwood City 11
San Francisco 11
Kronberg 9
Salerno 9
Ankara 8
Council Bluffs 8
Curitiba 8
Hải Dương 8
Roubaix 8
Vienna 8
Woodbridge 8
Amman 7
Biên Hòa 7
Buenos Aires 7
Falls Church 7
Guayaquil 7
Karachi 7
Porto Alegre 7
Portsmouth 7
Pune 7
Ribeirão Preto 7
Salt Lake City 7
Shanghai 7
Tashkent 7
Toronto 7
Turin 7
Viareggio 7
Baghdad 6
Bexley 6
Bologna 6
Guangzhou 6
Guarulhos 6
Lauterbourg 6
Lima 6
Messina 6
Ninh Bình 6
Totale 6.000
Nome #
Performance analysis of SiRe next-generation sequencing panel in diagnostic setting: focus on NSCLC routine samples 176
Cell free DNA analysis by SiRe® next generation sequencing panel in non small cell lung cancer patients: focus on basal setting. 153
The Metallophosphoesterase-Domain-Containing Protein 2 (MPPED2) Gene Acts as Tumor Suppressor in Breast Cancer 145
Next generation sequencing techniques in liquid biopsy: focus on non-small cell lung cancer patients 130
Liquid biopsy as indication of tumour progression in lung cancer: A potential intervention in tertiary prevention 129
A Roadmap for a Comprehensive Diagnostic Approach to Fine Needle Cytology of Lymph Node Metastases 125
Evaluation of the Molecular Landscape in PD-L1 Positive Metastatic NSCLC: Data from Campania, Italy 124
PD-L1 expression in cell-blocks of non-small cell lung cancer: The impact of prolonged fixation 124
Genomic profiling of tissue and blood predicts survival outcomes in patients with resected pleural mesothelioma 124
Technical Validation of a Fully Integrated NGS Platform in the Real-World Practice of Italian Referral Institutions 117
A MiR181/Sirtuin1 regulatory circuit modulates drug response in biliary cancers 116
RNA-based next generation sequencing in non-small-cell lung cancer in a routine setting: an experience from an Italian referral center 115
Predictive molecular pathology in metastatic thyroid cancer: the role of RET fusions 115
Liquid biopsy for BRAF mutations testing in non-small cell lung cancer: A retrospective study 113
ALK and ROS1 testing on lung cancer cytologic samples: Perspectives 112
Impact of Pre-Analytical Factors on MSI Test Accuracy in Mucinous Colorectal Adenocarcinoma: A Multi-Assay Concordance Study 111
Moving towards a local testing solution for undetermined thyroid fine-needle aspirates: validation of a novel custom DNA-based NGS panel 108
Comparison of two next-generation sequencing-based approaches for liquid biopsy analysis in patients with non-small cell lung cancer: a multicentre study 107
Non-Small Cell Lung Cancer Testing on Reference Specimens: An Italian Multicenter Experience 107
Development of a gene panel for next-generation sequencing of clinically relevant mutations in cell-free DNA from cancer patients 106
Multiplex digital colour-coded barcode technology on RNA extracted from routine cytological samples of patients with non-small cell lung cancer: pilot study 106
Evaluation of BRAF, RAS, RET/PTC, and PAX8/PPARg alterations in different Bethesda diagnostic categories: A multicentric prospective study on the validity of the 7-gene panel test in 1172 thyroid FNAs deriving from different hospitals in South Italy 105
The continuing role of breast fine-needle aspiration biopsy after the introduction of the IAC Yokohama System For Reporting Breast Fine Needle Aspiration Biopsy Cytopathology 104
Rapid On-site Molecular Evaluation in thyroid cytopathology: A same-day cytological and molecular diagnosis 103
Evaluation of a fully closed real time PCR platform for the detection of SARS-CoV-2 in nasopharyngeal swabs: a pilot study 102
The role of liquid biopsy in epithelial ovarian cancer: state of the art 101
Circulating tumor DNA in cancer: Predictive molecular pathology meets mathematics 101
The biomarkers ATLAS: An audit on 1100 non-small cell lung cancer from an Italian knowledge-based database 100
Liquid Biopsy in Prostate Cancer Management{\textemdash}Current Challenges and Future Perspectives 100
PIK3CA testing in hormone receptor-positive/HER2-negative metastatic breast cancer: real-world data from Italian molecular pathology laboratories 99
RNA-Based Assay for Next-Generation Sequencing of Clinically Relevant Gene Fusions in Non-Small Cell Lung Cancer 99
Brca1/2 ngs somatic testing in clinical practice: a short report 99
The evolving role of liquid biopsy in lung cancer 98
EGFR mutation detection on lung cancer cytological specimens by the novel fully automated PCR-based Idylla EGFR Mutation Assay 98
Cytology meets next generation sequencing and liquid biopsy: A case of lung adenocarcinoma presenting as metastasis to the phalanx 98
Next Generation Sequencing for liquid biopsy based testing in Non-Small Cell Lung Cancer in 2021 98
How Molecular and Ancillary Tests Can Help in Challenging Cytopathology Cases: Insights from the International Molecular Cytopathology Meeting 97
Next generation sequencing in cytology 97
Multiple predictive biomarker testing in melanoma: another challenge for the optimal approach on cytological samples 96
Recent advances in the use of liquid biopsy for the diagnosis and treatment of lung cancer 96
Ciliated foregut cyst of the pancreas: A benign lesion with elevated CEA levels 96
KRAS mutations testing in non-small cell lung cancer: The role of Liquid biopsy in the basal setting 96
Harmonization of Next-Generation Sequencing Procedure in Italian Laboratories: A Multi-Institutional Evaluation of the SiRe® Panel 96
A narrative review of lung cancer cytology in the times of coronavirus: What physicians should know 96
Role of Cytomorphology in the Era of Liquid Biopsy 95
Evaluation of Micro Satellite Instability and Mismatch Repair Status in Different Solid Tumors: A Multicenter Analysis in a Real World Setting 95
Methods for actionable gene fusion detection in lung cancer: now and in the future 95
PD-L1 expression on routine samples of non-small cell lung cancer: Results and critical issues from a 1-year experience of a centralised laboratory 94
Unusual Clinical Experience in BRAF Exon 15 p.K601E-Mutated Lung Cancer: A Case Report and Brief Review of the Literature 93
Osimertinib 93
Is the Idylla EGFR Mutation Assay feasible on archival stained cytological smears? A pilot study 93
There is still a role for cytology in the 'liquid biopsy' era. A lesson from a TKI-treated patient showing adenocarcinoma to squamous cell carcinoma transition during disease progression 92
BRAF mutations in lung cancer 92
Mismatch repair proteins and microsatellite instability in solid pseudopapillary neoplasm of the pancreas 92
Predictive molecular pathology in the time of COVID-19 91
Interventional cytopathologist can successfully combine ultrasonographical and microscopic skills to narrow the differential diagnosis in fine‐needle aspiration of neck paraganglioma 90
Comparison between two different next generation sequencing platforms for clinical relevant gene mutation test in solid tumours 90
Multi-gene custom panels for the characterisation of metastatic colorectal carcinoma in clinical practice: express the role of PIK3CA mutations 90
Dealing with NSCLC EGFR mutation testing and treatment: A comprehensive review with an Italian real-world perspective 90
An Italian Multicenter Perspective Harmonization Trial for the Assessment of MET Exon 14 Skipping Mutations in Standard Reference Samples 89
The evolving role of interventional cytopathology from thyroid FNA to NGS: Lessons learned at Federico II University of Naples 89
EGFR mutation detection on routine cytological smears of non-small cell lung cancer by digital PCR: A validation study 89
KRAS, NRAS and BRAF mutations detected by next generation sequencing, and differential clinical outcome in metastatic colorectal cancer (MCRC) patients treated with first line FIr-B/FOx adding bevacizumab (BEV) to triplet chemotherapy 89
KRAS detection on archival cytological smears by the novel fully automated polymerase chain reaction-based Idylla mutation test 89
TargetPlex FFPE-Direct DNA Library Preparation Kit for SiRe NGS panel: an international performance evaluation study 89
A narrative review of predictive immuno-histo/cyto chemistry in lung cancer: focus on gene fusions and PD-L1 expression 88
Next Generation Sequencing in Cytopathology: Focus on Non-Small Cell Lung Cancer 88
BRAF: A Two-Faced Janus 87
Interobserver variability in cytopathology: How much do we agree? 86
Microsatellite instability evaluation of patients with solid tumour: routine practice insight from a large series of Italian referral centre 86
A challenging case of enteric-type lung adenocarcinoma metastatic to the thyroid harboring RET-fusion diagnosed on fine-needle aspiration 85
Less frequently mutated genes in colorectal cancer: Evidences from next-generation sequencing of 653 routine cases 85
Tumor mutational burden on cytological samples: A pilot study 85
Consistency and reproducibility of next-generation sequencing in cytopathology: A second worldwide ring trial study on improved cytological molecular reference specimens 84
Fine-Needle Aspiration Is Suitable for Breast Cancer BRCA Molecular Assessment: A Case Report 84
How to prepare cytological samples for molecular testing 83
Liquid Biopsy and Lung Cancer 82
Invited review—next-generation sequencing: a modern tool in cytopathology 82
Profile of the Roche cobas® EGFR mutation test v2 for non-small cell lung cancer 81
EGFR exon 19 deletion switch and development of p.L792Q mutation as a new resistance mechanism to osimertinib: A case report and literature review 80
Next generation sequencing identifies novel potential actionable mutations for grade I meningioma treatment 80
Cytopathology practice during the COVID-19 postlockdown: An Italian experience 80
COVID-19 pandemic impact on cytopathology practice in the post-lockdown period: An international, multicenter study 80
BRAF as a positive predictive biomarker: Focus on lung cancer and melanoma patients 79
Evaluating local thyroid cytopathology practices by molecular quality metrics: A multi‐institutional study on 4651 FNAs with a focus on the role of the interventional cytopathologist 79
Molecular testing in salivary gland cytopathology: A practical overview in conjunction with the Milan system 77
Tissue Microarray from Cell Block Material (cbTMA)—An Additional Shot for Cytology in the Predictive Pathology Era: The PD-L1 Experience 76
Critical aspects of MSI testing in endometrial cancer: a comparison study 75
A simplified genomic profiling approach predicts outcome in metastatic colorectal cancer 75
Bird's eye view of modern cytopathology: Report from the seventh international Molecular Cytopathology Meeting in Naples, Italy, 2018 74
RNA-Based Next-Generation Sequencing in Non-Small Cell Lung Cancer patients: data from Campania, Italy 73
Juggling the COVID-19 pandemic: A cytopathology point of view 72
Biologics for novel driver altered non-small cell lung cancer: potential and pitfalls 70
Cytopathologists can reliably perform ultrasound-guided thyroid fine needle aspiration: a 1-year audit on 3715 consecutive cases 70
Global impact of the COVID-19 pandemic on cytopathology practice: Results from an international survey of laboratories in 23 countries 67
Prevalence of KRAS, NRAS and BRAF mutations detected by massive parallel sequencing and differential clinical outcome in metastatic colorectal cancer (MCRC) patients (pts) treated with first line FIr-B/FOx adding bevacizumab (BEV) to triplet chemotherapy 66
Consistency and reproducibility of next-generation sequencing and other multigene mutational assays: A worldwide ring trial study on quantitative cytological molecular reference specimens 66
Molecular Testing of Thyroid Fine-Needle Aspiration: Local Issues and Solutions. An Interventional Cytopathologist Perspective 64
A narrative review on the implementation of liquid biopsy as a diagnostic tool in thoracic tumors during the COVID-19 pandemic 64
Interventional cytopathologist perspective on the Milan System Classification: a study on 929 consecutive salivary gland fine-needle aspirations with a focus on challenging diagnostic categories 62
Totale 9.472
Categoria #
all - tutte 40.264
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 40.264


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021245 0 0 0 0 0 69 20 49 31 34 21 21
2021/2022586 38 14 18 9 9 12 16 64 21 45 125 215
2022/2023898 113 54 38 65 120 111 4 106 169 44 57 17
2023/2024700 42 118 50 28 29 37 25 95 22 38 124 92
2024/20254.315 198 233 21 21 98 183 457 265 303 615 1.530 391
2025/20264.813 847 784 894 769 1.389 130 0 0 0 0 0 0
Totale 11.893